Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharmaceutical Industries Ltd eases for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1689.8, down 0.22% on the day as on 13:19 IST on the NSE. The stock jumped 1.41% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.
Amfi seeks use of intraday loans to buy securities as Sebi defers strict mutual fund borrowing norms
India's mutual fund body is engaging with the market regulator after fund houses raised concerns that limiting intraday loans mainly for redemptions could severely hamper their ability to acquire securities.

We asked a hedge fund manager to explain Thursday's spike in Indian stocks. Here's what he said.
On Thursday, the Nifty 50 bounced nearly 500 points from the day's low, and the Nifty Bank jumped over 1,600 points, inexplicably. The late rally on the last trading day of last week has given way to wild swings in the market this Monday.
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top Losers - Equitymaster
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top LosersEquitymaster

Where are the Indian markets headed? Here's a bull case Vs bear case scenario
Brokerages remain divided on India’s market outlook amid global uncertainties. Jefferies, ICICI Prudential AMC and 3P Investment Managers are positive on India, driven by improved valuations, limited earnings downside and supportive domestic flows. They highlight attractive Nifty valuations, favourable allocation signals and recent market correction as key reasons to increase exposure, with a preference for sectors like banks and pharma and a gradual approach to adding equities. On the other hand, Nomura, Goldman Sachs and UBS remain cautious, citing rising oil prices, weak foreign flows and global risks that could weigh on growth and market returns in the near term.

Nifty Pharma index drops 3% as US tariff fears hit Sun Pharma, peers
A Bloomberg report indicated that the Trump administration is planning tariffs on pharmaceutical companies that have not entered into agreements to ensure lower drug prices in the US.

SBI MF Highest, Parag Parikh Not So Much: Mutual Fund Houses That Have Top Exposure To HDFC Bank
Indian mutual funds lost Rs 31,900 crore in wealth as HDFC Bank shares tumbled following the sudden resignation of its part-time chairman.
FPIs pull out Rs 89,916 crore in record 15-day sell-off, Nifty slides 10%
Foreign investors have withdrawn a record 89,916 crore from Indian stocks. This outflow over 15 sessions is the largest in two decades. Domestic mutual funds bought 71,183 crore to support the market. Previous heavy selling by foreign investors was also cushioned by domestic fund purchases.
Coal India's arm CMPDIL raises ₹470 cr via anchor investors ahead of IPO
Central Mine Planning and Design Institute (CMPDIL), an arm of state-owned Coal India, on Wednesday said it has mobilised Rs 470 crore from anchor investors, ahead of its initial share-sale opening for public subscription. Life Insurance Corporation (LIC), Nippon India Mutual Fund (MF), Edelweiss MF, ICICI Prudential MF, Baring Private Equity India Fund, General Insurance Corporation of India and Edelweiss Life Insurance Corporation are among the anchor investors, according to a circular uploaded on BSE's website. Also, Societe Generale, Citigroup, Goldman Sachs and BNP Paribas Financial Markets participated in the anchor round. As per the circular, the state-owned firm allotted 2.73 crore equity shares to 22 funds at Rs 172 per piece, aggregating the transaction size to Rs 469.74 crore. Of these funds, LIC has been allocated shares to the tune of Rs 105 crore. CMPDIL's Rs 1,842-crore initial public offering (IPO) will open for subscription on March 20 and conclude on March 24. T
Unique Picks: 10 stocks held by only one MF scheme in February; 4 jumped up to 140%
ETMarkets identified 24 stocks held exclusively by single mutual fund schemes, most declining sharply in FY26, while a few delivered strong gains, highlighting concentrated ownership risks and divergent performance trends.

Vinit Sambre positive on insurance, private banks; favors IT firms on skilling and capital disciplin
Vinit Sambre, Head of Equities, DSP Mutual Fund, which manages funds worth $24.30 billion for the period of October-December 2025, said recent market volatility has brought valuations to more reasonable levels, with macro indicators like credit growth and auto sales still improving. He expects growth to recover after near-term disruptions and sees opportunities emerging in IT and BFSI. While uncertainty remains due to global risks, he suggests gradual equity allocation, maintaining a balanced approach with diversified funds and selective deployment as clarity improves.

SBI MF buys 4% in Urban Company via bulk deals; Wellington, others pare stake
SBI Mutual Fund acquired a 4% stake in Urban Company for ₹632 crore through bulk deals, while existing investors including Wellington and DF International Partners pared holdings in the company.